466 results on '"Jacob-Nara, Juby A"'
Search Results
2. Reduced Sense of Smell in Patients with Severe Chronic Rhinosinusitis and its Implications for Diagnosis and Management: A Narrative Review
3. Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE)
4. Comparative effectiveness of dupilumab and omalizumab on asthma exacerbations and systemic corticosteroid prescriptions: Real-world US ADVANTAGE study
5. Dupilumab response onset, maintenance, and durability in patients with severe CRSwNP
6. Mild and symptom-free months in patients with chronic rhinosinusitis with nasal polyps treated with dupilumab
7. Type 2 Inflammation and Asthma in Children: A Narrative Review
8. Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma
9. Impact of dupilumab across seasons in patients with type 2, uncontrolled, moderate-to-severe asthma
10. Real-world effectiveness of dupilumab in patients with asthma: Findings from the US ADVANTAGE study
11. Dupilumab sustains lung function improvements in patients with moderate-to-severe asthma
12. Dupilumab Efficacy and Safety in Children With Moderate to Severe Asthma and High Blood Eosinophils: A Post Hoc Analysis of VOYAGE
13. Disease Burden and Spectrum of Symptoms That Impact Quality of Life in Pediatric Patients With Eosinophilic Esophagitis
14. Dupilumab Induces Long-term On-Treatment Clinical Remission in Patients With Type 2 Asthma
15. Dupilumab efficacy in high sleep disturbance management among patients with type 2 asthma
16. Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry
17. Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma
18. Dupilumab Efficacy in Patients With Uncontrolled or Oral Corticosteroid–Dependent Allergic and Nonallergic Asthma
19. The long-term effect of dupilumab on dyspnea, sleep, and activity in oral corticosteroid-dependent severe asthma
20. Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction
21. Long-term efficacy of dupilumab in asthma with or without chronic rhinosinusitis and nasal polyps
22. Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma recruited from Japanese centers in the phase 3 LIBERTY ASTHMA TRAVERSE study
23. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis
24. Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline
25. Dupilumab Efficacy in Steroid-Dependent Severe Asthma by Baseline Oral Corticosteroid Dose
26. Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma: An Analysis of the Phase 3, Open-Label Extension TRAVERSE Trial
27. Dupilumab 200 mg was efficacious in children (6–11 years) with moderate‐to‐severe asthma for up to 2 years: EXCURSION open‐label extension study.
28. DUPILUMAB IMPROVES ASTHMA CONTROL AND REDUCES FRACTIONAL EXHALED NITRIC OXIDE AND EXACERBATIONS WITH INHALED CORTICOSTEROID WITHDRAWAL: A PHASE 2 STUDY.
29. Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis.
30. Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies
31. Preclinical and clinical experience with dupilumab on the correlates of live attenuated vaccines
32. Examining the Role of Type 2 Inflammation in Eosinophilic Esophagitis
33. The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps
34. DUPILUMAB SAFETY AND EFFICACY IN A REAL-WORLD CLINICAL SETTING: THE RAPID ASTHMA REGISTRY
35. ASSESSING THE IMPACT OF ASTHMA CONTROL QUESTIONNAIRE SCORE CUTOFFS WITHIN THE MULTICOMPONENT CLINICAL REMISSION ENDPOINT ON CLINICAL OUTCOMES: TRAVERSE OPEN-LABEL STUDY
36. BASELINE CHARACTERISTICS AND COEXISTING TYPE 2 INFLAMMATORY DISEASES OF PATIENTS WITH ASTHMA INITIATING DUPILUMAB IN A REAL-WORLD SETTING: THE RAPID REGISTRY
37. BASELINE CHARACTERISTICS OF PATIENTS ON MEDIUM- VS HIGH-DOSE INHALED CORTICOSTEROIDS IN PATIENTS INITIATING DUPILUMAB IN A REAL-WORLD CLINICAL SETTING: THE RAPID REGISTRY
38. CLINICAL EFFICACY OF DUPILUMAB TREATMENT DURING WITHDRAWAL OF INHALED CORTICOSTEROIDS/LONG-ACTING BETA AGONISTS
39. Association Between Smell Loss, Disease Burden, and Dupilumab Efficacy in Chronic Rhinosinusitis with Nasal Polyps.
40. Real-world effectiveness of dupilumab versus benralizumab and mepolizumab.
41. Dupilumab reduces exacerbations independent of changes in biomarkers in moderate-to-severe asthma
42. Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study
43. Evaluating the Effect of Dupilumab on Type 2 Airway Inflammation and Mucus Plugging in Patients with Uncontrolled Moderate-To-Severe Asthma: the VESTIGE Trial
44. Asthma Treatment With Add-On Dupilumab Plus Medium-Dose Inhaled Corticosteroid (ICS) Improved Lung Function and Asthma Control Compared With Placebo Plus High-Dose ICS
45. Prevalence of NSAID-ERD Among Patients with Chronic Rhinosinusitis with Nasal Polyps in the Global AROMA registry
46. Impact of Lung Function on Asthma Exacerbation Rates in Children Treated with Dupilumab: The VOYAGE Study
47. Baseline Disease Characteristics Among Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma in the Global AROMA registry
48. Long-Term Efficacy Of Dupilumab In Patients With Moderate-To-Severe Type 2 Asthma Stratified By Baseline Characteristics During The 96-Week TRAVERSE Study
49. Improved Lung Function is Associated With Better Asthma Control in Children Aged 6 to 11 Years With Moderate-To-Severe Type 2 Asthma: A Post Hoc Analysis of VOYAGE
50. Coexisting Allergic Rhinitis In Patients With Moderate-To-Severe Asthma Initiating Dupilumab In Real-World Clinical Practice: The RAPID Registry Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.